Home Clinical Topics FDA approves first treatment for pediatric patients with lupus

FDA approves first treatment for pediatric patients with lupus

Author(s):

On April 26, the FDA approved Benlysta (belimumab) I.V. infusion for treatment of children with systemic lupus erythematosus (SLE). This is the first FDA-approved treatment for pediatric patients with SLE.

Read more at fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here